• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAchilles Therapeutics
    Picture of Achilles Therapeutics logo

    ACHL — Achilles Therapeutics News Story

    $1.480.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $60.83m
    • Enterprise Value
      -$25.22m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACHL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACHL Dividends
    All News

    NASDAQ RESUMED AT 09:56 AM

    Picture of Achilles Therapeutics logoAchilles Therapeutics
    11/08/2021 14:56
    NASDAQ RESUMED  ACHL.O  AT 09:56 AM
    

    Recent news on Achilles Therapeutics

    See all news
    • Brief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca

      24/12/2024 14:37
    • Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market

      19/11/2024 12:04
    • Achilles gains on plans to explore strategic options

      19/09/2024 19:18
    • Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy

      19/09/2024 12:40
    • Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

      17/05/2024 22:01

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.